Radiation therapy projects
Advanced techniques and technology in radiation oncology are continually evolving. This requires the TROG Cancer Research QA team to remain adaptable and relevant. The QA team collaborate on a range of special projects.
Recent highlights include:
Sensitivity assessment systems to improve quality in radiation oncology treatments is a novel project that seeks to identify pilot methods, to systematically and remotely, test the sensitivity of a centres’ Patient-Specific Quality Assurance (PSQA) procedures, in order to detect clinically relevant treatment delivery problems.
The Primary Investigator of this project is Associate Professor Joerg Lehmann.
Virtual EPID Standard Phantom Audit (VESPA) is a novel remote method for external dosimetric Treatment Planning System (TPS), planned auditing of Intensity Modulated Radiotherapy (IMRT), and Volumetric Modulated Arc Therapy (VMAT) for clinical trials using an Electronic Portal Imaging Device (EPID).
The Primary Investigator of this project is Professor Peter Greer.
A novel approach to TROG Cancer Research RTQA methods is currently being piloted using Knowledge-Based Planning (KBP) (via Varian’s RapidPlan software) to provide a systematic method for patient-specific qualitative feedback.
TROG Cancer Research clinical trials involved in the pilot program include: TROG 15.01 SPARK, TROG 15.03 FASTRACK II, TROG 17.03 LARK and TROG 18.01 NINJA.
TROG RapidPlan Models are NOW AVAILABLE via mediated access for the following trials:
Please contact qa@trog.com.au for login details.
In 2021, TROG received vital pilot funding from Tour de Cure to facilitate the establishment of the TROG National Cancer Imaging Databank – a unique and important digital resource to improve patient outcomes in radiation oncology research.
This Cancer Imaging Databank resource, hosted via the Elekta ProKnow software will allow us to leverage important clinical trial data, maximising its utility and will facilitate insights that can only be made possible when data is pooled in parallel with powerful analytical platforms. It will allow future secondary analysis of data which is both cost-effective and efficient, meaning important clinical questions can be more rapidly answered.
In collaboration with Elekta ProKnow, TROG has conducted several Plan Challenges and Contouring Accuracy Studies in recent years.
Although these challenges have closed and the winners have been announced, you are still able to participate. Visit: Elekta ONE | Plan Analytics News | Elekta ProKnow | Oncology Informatics | Products | Elekta.
TROG Plan Challenges:
TROG Contouring Accuracy:
The TROG QA team has been collaborating with MIM Software and project leads across several clinical trials to develop streamlined and efficient workflows that support individual case review processes. Recent projects utilising MIM Software include:
Global Harmonization Group
Collaboration with other groups and organisations is a cornerstone of the TROG QA framework.
TROG is a proud member of the Global Harmonization Group (GHG). This group aims to harmonise and improve RTQA processes and procedures across international multi-institutional cooperative clinical trials groups. The opportunity to share knowledge, processes and information with these groups is key to the way TROG conducts clinical trial programs.
Contact us
If you require any further information or want to discuss collaborating with TROG, don’t hesitate to contact us at: qa@trog.com.au
Have your say – provide feedback today
The TROG QA team are always seeking to improve processes and systems. We value positive and constructive feedback from our members and clinical trials colleagues.
If you have any feedback or suggestions relevant to TROG QA, please feel free to complete our feedback survey or contact us.
